Abstract:[Objective] To analyze the hidden blood loss in oblique lumbar interbody fusion (OLIF) for degenerative lumbar diseases, and the factors related to it. [Methods] A retrospective analysis was performed on 45 patients who received OLIF for degenerative lumbar diseases in our hospital from May 2016 to December 2019. The hidden blood loss was calculated, and the factors related to hidden blood loss were screened out by stratification factors and multiple linear stepwise regression analysis. [Results] All patients had operation completed success- fully, with operation time of (183.36±62.53) min, the dominant blood loss of (120.78±108.31) ml. The mean total blood loss was (758.95± 393.05) ml while the hidden blood loss was (638.17±371.75) ml, accounting for (81.09±16.54) % of the total blood loss. There were no statisti- cally significant differences in hidden blood loss in terms of stratification of age, sex, BMI, number of surgical levels, diabetes, hypertension, spinal deformity, and bone graft type (P<0.05) . However, there were statistically significant differences in hidden blood loss by stratifications of operation time, learning curve, and whether or not tranexamic acid used (P<0.05) . As results of multiple linear stepwise regression, the learn- ing curve (number of surgical sequence) (B=-12.171, P=0.002) and the amount of tranexamic acid used (B=-246.090, P=0.015) were signifi- cantly negatively correlated with the amount of hidden blood loss. [Conclusion] There is considerable amount of hidden blood loss in OLIF for degenerative lumbar diseases, which is closely related to learning curve and tranexamic acid usage, should be paid attention to by clinicians.